• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于5-羟色胺2A受体精神活性物质识别的机器学习领域3D-QSAR模型。

Machine learning field 3D-QSAR models for serotonin 2A receptor psychoactive substances identification.

作者信息

Floresta Giuseppe, Abbate Vincenzo

机构信息

Department of Analytical, Environmental and Forensic Sciences, King's College London London UK

出版信息

RSC Adv. 2021 Apr 20;11(24):14587-14595. doi: 10.1039/d1ra01335a. eCollection 2021 Apr 15.

DOI:10.1039/d1ra01335a
PMID:35424006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8697832/
Abstract

Serotonergic psychedelics, substances exerting their effects primarily through the serotonin 2A receptor (5HT2AR), continue to comprise a substantial portion of reported new psychoactive substances (NPS). In this paper five quantitative structure-activity relationship (QSAR) models for predicting the affinity of 5-HT2AR ligands have been developed. The resulting models, exploiting the accessibility of the QSAR equations, generate a useful tool for the investigation and identification of unclassified molecules. The models have been built using a set of 375 molecules using Forge software, and the quality was confirmed by statistical analysis, resulting in effective tools with respect to their predictive and descriptive capabilities. The best performing algorithm among the machine learning approaches and the classical field 3D-QSAR model were then combined to produce a consensus model and were exploited, together with a pharmacophorefilter, to explore the 5-HT2AR activity of 523 105 natural products, to classify a set of recently reported 5-HT2AR NPS and to design new potential active molecules. The findings of this study should facilitate the identification and classification of emerging 5-HT2AR ligands including NPS.

摘要

血清素能致幻剂主要通过血清素2A受体(5HT2AR)发挥作用,在新出现的精神活性物质(NPS)报告中仍占很大比例。本文建立了五个用于预测5-HT2AR配体亲和力的定量构效关系(QSAR)模型。利用QSAR方程的可及性,所得模型为未分类分子的研究和鉴定提供了有用工具。这些模型使用Forge软件,基于一组375个分子构建,通过统计分析确认了其质量,从而形成了具有预测和描述能力的有效工具。然后将机器学习方法中表现最佳的算法与经典的场3D-QSAR模型相结合,生成一个共识模型,并与药效团过滤器一起用于探索523105种天然产物的5-HT2AR活性,对一组最近报告的5-HT2AR NPS进行分类,并设计新的潜在活性分子。本研究结果应有助于识别和分类包括NPS在内的新型5-HT2AR配体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/69a1345b44bc/d1ra01335a-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/2b2a360a8d46/d1ra01335a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/7aac95af85e6/d1ra01335a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/c1c5a947f062/d1ra01335a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/fbfda8386747/d1ra01335a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/38589db92b52/d1ra01335a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/e18cb3d7fb67/d1ra01335a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/1d23582d9e34/d1ra01335a-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/71a5d4f2133f/d1ra01335a-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/e8f33b8e704c/d1ra01335a-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/69a1345b44bc/d1ra01335a-f10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/2b2a360a8d46/d1ra01335a-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/7aac95af85e6/d1ra01335a-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/c1c5a947f062/d1ra01335a-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/fbfda8386747/d1ra01335a-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/38589db92b52/d1ra01335a-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/e18cb3d7fb67/d1ra01335a-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/1d23582d9e34/d1ra01335a-f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/71a5d4f2133f/d1ra01335a-f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/e8f33b8e704c/d1ra01335a-f9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b99/8697832/69a1345b44bc/d1ra01335a-f10.jpg

相似文献

1
Machine learning field 3D-QSAR models for serotonin 2A receptor psychoactive substances identification.用于5-羟色胺2A受体精神活性物质识别的机器学习领域3D-QSAR模型。
RSC Adv. 2021 Apr 20;11(24):14587-14595. doi: 10.1039/d1ra01335a. eCollection 2021 Apr 15.
2
Structure-Based Approach for the Prediction of Mu-opioid Binding Affinity of Unclassified Designer Fentanyl-Like Molecules.基于结构的方法预测未分类的芬太尼类设计分子对μ-阿片受体的结合亲和力。
Int J Mol Sci. 2019 May 10;20(9):2311. doi: 10.3390/ijms20092311.
3
In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor.通过β-arrestin 2 募集到血清素 2A 受体来测定 30 种致幻新型精神活性物质的体外结构-活性关系。
Arch Toxicol. 2020 Oct;94(10):3449-3460. doi: 10.1007/s00204-020-02836-w. Epub 2020 Jul 5.
4
Setup of a Serotonin 2A Receptor (5-HT2AR) Bioassay: Demonstration of Its Applicability To Functionally Characterize Hallucinogenic New Psychoactive Substances and an Explanation Why 5-HT2AR Bioassays Are Not Suited for Universal Activity-Based Screening of Biofluids for New Psychoactive Substances.建立血清素 2A 受体(5-HT2AR)生物测定法:论证其在功能性鉴定致幻新型精神活性物质方面的适用性,以及为什么 5-HT2AR 生物测定法不适用于新型精神活性物质的生物流体通用基于活性的筛选。
Anal Chem. 2019 Dec 17;91(24):15444-15452. doi: 10.1021/acs.analchem.9b03104. Epub 2019 Nov 27.
5
Identification of psychedelic new psychoactive substances (NPS) showing biased agonism at the 5-HTR through simultaneous use of β-arrestin 2 and miniGα bioassays.通过同时使用β-抑制蛋白2和miniGα生物测定法鉴定对5-羟色胺受体表现出偏向性激动作用的致幻新型精神活性物质(NPS)。
Biochem Pharmacol. 2020 Dec;182:114251. doi: 10.1016/j.bcp.2020.114251. Epub 2020 Sep 28.
6
Discovery of High-Affinity Cannabinoid Receptors Ligands through a 3D-QSAR Ushered by Scaffold-Hopping Analysis.通过基于构象搜索的 3D-QSAR 发现高亲和力大麻素受体配体。
Molecules. 2018 Aug 30;23(9):2183. doi: 10.3390/molecules23092183.
7
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands.用于鉴定潜在强效和选择性σ-2受体配体的联用3D-QSAR统计模型-骨架跃迁分析
Eur J Med Chem. 2017 Oct 20;139:884-891. doi: 10.1016/j.ejmech.2017.08.053. Epub 2017 Aug 25.
8
Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT Receptor Agonists in Mice.迷幻和非迷幻 5-HT 受体激动剂在小鼠中的耐受性和交叉耐受性。
ACS Chem Neurosci. 2022 Aug 17;13(16):2436-2448. doi: 10.1021/acschemneuro.2c00170. Epub 2022 Jul 28.
9
identification of novel 5-HT antagonists supported with ligand- and target-based drug design methodologies.基于配体和基于靶点的药物设计方法鉴定新型 5-HT 拮抗剂。
J Biomol Struct Dyn. 2021 Mar;39(5):1819-1837. doi: 10.1080/07391102.2020.1738961. Epub 2020 Mar 17.
10
New serotonin 5-HT(2A), 5-HT(2B), and 5-HT(2C) receptor antagonists: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo and heterocycloalkanones.新型5-羟色胺5-HT(2A)、5-HT(2B)和5-HT(2C)受体拮抗剂:(氨基烷基)苯并和杂环烷酮的合成、药理学、三维定量构效关系及分子模拟
J Med Chem. 2002 Jan 3;45(1):54-71. doi: 10.1021/jm011014y.

引用本文的文献

1
Synthesis and biological assessment of chalcone and pyrazoline derivatives as novel inhibitor for ELF3-MED23 interaction.查尔酮和吡唑啉衍生物作为ELF3-MED23相互作用新型抑制剂的合成与生物学评估
Elife. 2024 Dec 5;13:RP97051. doi: 10.7554/eLife.97051.
2
Integration of machine learning in 3D-QSAR CoMSIA models for the identification of lipid antioxidant peptides.机器学习在用于鉴定脂质抗氧化肽的3D-QSAR CoMSIA模型中的整合。
RSC Adv. 2023 Nov 17;13(48):33707-33720. doi: 10.1039/d3ra06690h. eCollection 2023 Nov 16.
3
Applications and Potential of In Silico Approaches for Psychedelic Chemistry.

本文引用的文献

1
New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review.新型精神活性物质(NPS)与血清素综合征发病:系统评价。
Exp Neurol. 2021 May;339:113638. doi: 10.1016/j.expneurol.2021.113638. Epub 2021 Feb 8.
2
An Integrated Pharmacophore/Docking/3D-QSAR Approach to Screening a Large Library of Products in Search of Future Botulinum Neurotoxin A Inhibitors.一种整合的药效团/对接/3D-QSAR 方法,用于筛选大型产品库以寻找未来的肉毒神经毒素 A 抑制剂。
Int J Mol Sci. 2020 Dec 12;21(24):9470. doi: 10.3390/ijms21249470.
3
Structure of a Hallucinogen-Activated Gq-Coupled 5-HT Serotonin Receptor.
计算机模拟方法在迷幻药物化学中的应用与潜力
Molecules. 2023 Aug 9;28(16):5966. doi: 10.3390/molecules28165966.
4
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design.人工智能技术在新冠病毒从头设计药物中的应用。
Int J Mol Sci. 2022 Mar 17;23(6):3261. doi: 10.3390/ijms23063261.
致幻剂激活的 Gq 偶联 5-羟色胺受体的结构。
Cell. 2020 Sep 17;182(6):1574-1588.e19. doi: 10.1016/j.cell.2020.08.024.
4
In vitro structure-activity relationship determination of 30 psychedelic new psychoactive substances by means of β-arrestin 2 recruitment to the serotonin 2A receptor.通过β-arrestin 2 募集到血清素 2A 受体来测定 30 种致幻新型精神活性物质的体外结构-活性关系。
Arch Toxicol. 2020 Oct;94(10):3449-3460. doi: 10.1007/s00204-020-02836-w. Epub 2020 Jul 5.
5
Designer drugs: mechanism of action and adverse effects.设计药物:作用机制和不良反应。
Arch Toxicol. 2020 Apr;94(4):1085-1133. doi: 10.1007/s00204-020-02693-7. Epub 2020 Apr 6.
6
identification of novel 5-HT antagonists supported with ligand- and target-based drug design methodologies.基于配体和基于靶点的药物设计方法鉴定新型 5-HT 拮抗剂。
J Biomol Struct Dyn. 2021 Mar;39(5):1819-1837. doi: 10.1080/07391102.2020.1738961. Epub 2020 Mar 17.
7
Structure-Based Approach for the Prediction of Mu-opioid Binding Affinity of Unclassified Designer Fentanyl-Like Molecules.基于结构的方法预测未分类的芬太尼类设计分子对μ-阿片受体的结合亲和力。
Int J Mol Sci. 2019 May 10;20(9):2311. doi: 10.3390/ijms20092311.
8
Structures of the 5-HT receptor in complex with the antipsychotics risperidone and zotepine.5-HT 受体与抗精神病药利培酮和佐替平复合物的结构。
Nat Struct Mol Biol. 2019 Feb;26(2):121-128. doi: 10.1038/s41594-018-0180-z. Epub 2019 Feb 4.
9
3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation.3D-QSAR 辅助鉴定 FABP4 抑制剂:一种有效的骨架跃迁分析/QSAR 评价。
Bioorg Chem. 2019 Mar;84:276-284. doi: 10.1016/j.bioorg.2018.11.045. Epub 2018 Nov 29.
10
A Structure- and Ligand-Based Virtual Screening of a Database of "Small" Marine Natural Products for the Identification of "Blue" Sigma-2 Receptor Ligands.基于结构和配体的“小型”海洋天然产物数据库虚拟筛选,以鉴定“蓝色”sigma-2 受体配体。
Mar Drugs. 2018 Oct 14;16(10):384. doi: 10.3390/md16100384.